We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NGEN market cap is 124.02M. The company's latest EPS is CAD -0.3525 and P/E is -5.99.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 31k | 0 | 0 | 0 | 0 |
| Operating Income | -1.36M | -8.4M | -9.93M | -11.14M | -21.98M |
| Net Income | -1.36M | -9.77M | -11.19M | -12.73M | -20.72M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 3.1M | 6.77M | 6.68M | 17.9M | 23.88M |
| Total Liabilities | 583k | 924k | 755k | 1.08M | 10.41M |
| Total Equity | 2.51M | 5.84M | 5.92M | 16.82M | 13.46M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -1.04M | -8.09M | -6.31M | -8.27M | -17.78M |
| Investing | -127k | N/A | -3k | -44k | -21k |
| Financing | 3.59M | 9.84M | 7.85M | 19.61M | 22.64M |
| Market Cap | 124.02M |
| Price to Earnings Ratio | -5.99 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.52 |
| Price to Book Ratio | 9.21 |
| Dividend Yield | - |
| Shares Outstanding | 58.78M |
| Average Volume (1 week) | 100.65k |
| Average Volume (1 Month) | 83.47k |
| 52 Week Change | 33.54% |
| 52 Week High | 3.98 |
| 52 Week Low | 1.50 |
| Spread (Intraday) | 0.03 (1.41%) |
| Company Name | Nervgen Pharma Corporation |
| Address |
suite 2600, 595 burrard street vancouver, british columbia V7X 1L3 |
| Website | https://www.nervgenpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
